Evidence map›Paper›PMID 30967868›Full record

ReviewFrontiers in immunology2019

Role of the IgM Fc Receptor in Immunity and Tolerance.

Jun Liu, Ying Wang, Ermeng Xiong, Rongjian Hong, Qing Lu, Hiroshi Ohno, Ji-Yang Wang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Pooled it
  2. Trial
  3. Fc-engineering for improved cancer immunotherapy.Biochemical Society transactions · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jun LiuDepartment of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Ying WangDepartment of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Ermeng XiongDepartment of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Rongjian HongDepartment of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Qing LuDepartment of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Hiroshi OhnoRIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
Ji-Yang WangDepartment of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Fudan University · CNRIKEN Center for Integrative Medical Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunoglobulin (Ig) M is the first antibody isotype to appear during evolution, ontogeny and immune responses. IgM not only serves as the first line of host defense against infections but also plays an important role in immune regulation and immunological tolerance. For many years, IgM is thought to function by binding to antigen and activating complement system. With the discovery of the IgM Fc receptor (FcμR), it is now clear that IgM can also elicit its function through FcμR. In this review, we will describe the molecular characteristics of FcμR, its role in B cell development, maturation and activation, humoral immune responses, host defense, and immunological tolerance. We will also discuss the functional relationship between IgM-complement and IgM-FcμR pathways in regulating immunity and tolerance. Finally, we will discuss the potential involvement of FcμR in human diseases.

Indexed as

Lymphocyte ActivationAnimalsB-LymphocytesHumansImmune ToleranceImmunoglobulin MReceptors, FcImmunoglobulin Mimmunoglobulin M receptorReceptors, FcBCR signalcomplementFcμRhumoral immune responseIgM

Identifiers

PMID30967868
PMCPMC6438924
OpenAlexW2924878231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.